Atlas Trials

Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in Treatment of Metastatic Castration Resistant Prostate Cancer

Clinical trial NCT02218606 · COMPLETED

Trial details

NCT number
NCT02218606
Sponsor
Memorial Sloan Kettering Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2014-08-01
Primary completion
2023-10-13
Enrollment
81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.